CINC
CinCor Pharma Inc
$29.06
Earnings Summary
Revenue | $0Mn |
Net Profits | $-20.98Mn |
Net Profit Margins | -Inf% |
Highlights
CinCor Pharma Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2022. On a quarterly growth basis, CinCor Pharma Inc has generated NaN% jump in its revenue since last 3-months.
CinCor Pharma Inc’s net profit fell -132.47% since last year same period to $-20.98Mn in the Q3 2022. On a quarterly growth basis, CinCor Pharma Inc has generated 0.46% jump in its net profits since last 3-months.
CinCor Pharma Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2022. On a quarterly growth basis, CinCor Pharma Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the CinCor Pharma Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.55 |
EPS Estimate Current Year | -0.55 |
Highlights
CinCor Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.55 - a 6.67% jump from last quarter’s estimates.
CinCor Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.55.
Key Ratios
Key ratios of the CinCor Pharma Inc post its Q1 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
CinCor Pharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2023. This indicates that the CinCor Pharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-09 | -0.55 | 0 | 100% |
₹0 US Stocks a/c Opening Fee